As GDUFA Launch Nears, Is Sitting In The Backlog More Appealing?
This article was originally published in The Pink Sheet Daily
Executive Summary
More submissions are going into the generic drug backlog, likely because the backlog fee is expected to be less than half the GDUFA application fee.